INVESTORS & MEDIA

CAR-TCR Summit 2018

Sep 5, 2018 at 11:15 AM EDT


Additional Information

Dietmar Berger, M.D., Ph.D., the Company's Global Head of Research and Development, will give a presentation titled, “Phase 3 Development of tabcel ™, An Off-the-Shelf, Allogeneic T-Cell Immunotherapy for Epstein- Barr Virus Associated Lymphoma” on Wednesday, September 5, 2018 at 11:15 am EDT. The conference will be held at the Seaport Hotel & World Trade Center in Boston, MA.

 

Full Conference Agenda